Mylan Canada Welcomed as CHP Canada’s Newest Member
CHP Canada’s Board of Directors has approved Mylan Canada as our newest active member.
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, Mylan innovates to satisfy unmet needs; make reliability and service excellence a habit; do what’s right, not what’s easy; and impact the future through passionate global leadership. They offer a growing portfolio of more than 7,500 marketed products around the world, including antiretroviral therapies on which more than 40% of people being treated for HIV/AIDS globally depend. They market their products in more than 165 countries and territories. Mylan is one of the world’s largest producers of active pharmaceutical ingredients. Every member of their approximately 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at mylan.com. They routinely post information that may be important to investors on their website at investor.mylan.com.
Jeff Long, Head of Established Products at Mylan Canada, is excited to join CHP Canada as his team works on growing their OTC portfolio.
We are pleased to have Mylan on board and look forward to their input and collaboration in the years to come.
Welcome Mylan Canada!